Disease management in Europe.
作者信息
Richards T
出版信息
BMJ. 1998 Aug 15;317(7156):426-7. doi: 10.1136/bmj.317.7156.426.
Abstract
摘要
相似文献
1
Disease management in Europe.欧洲的疾病管理。
BMJ. 1998 Aug 15;317(7156):426-7. doi: 10.1136/bmj.317.7156.426.
2
The contribution of pharmaceutical companies: what's at stake for America. Executive summary from a report prepared by the Boston Consulting Group.
Ann N Y Acad Sci. 1994 Nov 4;729:111-26; discussion 139-42. doi: 10.1111/j.1749-6632.1994.tb12221.x.
3
[Health care in the USA depends more and more on drug industry].美国的医疗保健越来越依赖制药行业。
Lakartidningen. 2004 Sep 16;101(38):2915-7.
4
Health care lobbying: time to make patients the special interest.医疗保健游说：是时候将患者作为特殊利益群体了。
Am J Med. 2004 Apr 1;116(7):496-7. doi: 10.1016/j.amjmed.2004.02.011.
5
Austerity vs. growth--the impact of the current financial crisis on pharmaceutical innovation.紧缩与增长——当前金融危机对药物创新的影响
Int J Pharm. 2013 Feb 25;443(1-2):242-4. doi: 10.1016/j.ijpharm.2012.12.022. Epub 2013 Jan 4.
6
The future research agenda. A view from the pharmaceutical industry.未来的研究议程。来自制药行业的观点。
Pharmacoeconomics. 1994;6 Suppl 1:61-2. doi: 10.2165/00019053-199400061-00014.
7
Real value: a strategy for interventional cardiologists to lead healthcare reform.真正的价值：介入心脏病学家引领医疗改革的策略。
Catheter Cardiovasc Interv. 2014 Aug 1;84(2):188-91. doi: 10.1002/ccd.25159. Epub 2014 Feb 5.
8
Medical costs and the drug industry.医疗成本与制药行业。
Wall St J Midwest Ed. 1980 Apr 21;60(132):22.
9
Money, health, and the health care industry.金钱、健康与医疗保健行业。
Hosp Health Serv Adm. 1981 Winter;26(1):7-24.
10
Not cost-effective by design. Healthcare financing reform may share the same fate as the Titanic.从设计上看就不具有成本效益。医疗保健融资改革可能会和泰坦尼克号有同样的命运。
Med Econ. 2011 Dec 10;88(23):98, 93.
引用本文的文献
1
From shared care to disease management: key-influencing factors.从共享照护到疾病管理：关键影响因素
Int J Integr Care. 2001;1:e17. doi: 10.5334/ijic.22.
2
Powerlessness, control, and complexity: the experience of family physicians in a group model HMO.无力感、控制权与复杂性：团体模式健康维护组织中家庭医生的体验
Ann Fam Med. 2004 Mar-Apr;2(2):150-5. doi: 10.1370/afm.58.
3
Adoption of disease management model for diabetes in region of Maastricht.马斯特里赫特地区糖尿病疾病管理模式的采用。
BMJ. 2001 Oct 27;323(7319):983-5. doi: 10.1136/bmj.323.7319.983.
本文引用的文献
1
Patients with multiple chronic conditions--how many medications are enough?患有多种慢性病的患者——多少种药物才足够？
N Engl J Med. 1998 May 21;338(21):1541-2. doi: 10.1056/NEJM199805213382111.
2
Computers and the quality of care--a clinician's perspective.计算机与医疗质量——临床医生的视角
N Engl J Med. 1998 Jan 22;338(4):259-60. doi: 10.1056/NEJM199801223380411.
3
Disease management.疾病管理
BMJ. 1997 Jul 5;315(7099):50-3. doi: 10.1136/bmj.315.7099.50.
4
Managed care and disease management in the NHS.英国国家医疗服务体系中的管理式医疗与疾病管理
BMJ. 1996 Jul 20;313(7050):125-6. doi: 10.1136/bmj.313.7050.125.
5
Disease management: new wine in new bottles?疾病管理：旧瓶装新酒？
Ann Intern Med. 1996 May 1;124(9):838-42. doi: 10.7326/0003-4819-124-9-199605010-00009.
6
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.糖尿病强化治疗对胰岛素依赖型糖尿病长期并发症发生及进展的影响。
N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056/NEJM199309303291401.
Zotero 插件